These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21234388)

  • 1. The modulation of adaptive immune responses by bacterial zwitterionic polysaccharides.
    Stephen TL; Groneck L; Kalka-Moll WM
    Int J Microbiol; 2010; 2010():917075. PubMed ID: 21234388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How bacterial carbohydrates influence the adaptive immune system.
    Avci FY; Kasper DL
    Annu Rev Immunol; 2010; 28():107-30. PubMed ID: 19968562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological chemistry of immunomodulation by zwitterionic polysaccharides.
    Tzianabos A; Wang JY; Kasper DL
    Carbohydr Res; 2003 Nov; 338(23):2531-8. PubMed ID: 14670714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide processing and presentation by the MHCII pathway.
    Cobb BA; Wang Q; Tzianabos AO; Kasper DL
    Cell; 2004 May; 117(5):677-87. PubMed ID: 15163414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of surgical fibrosis by microbial zwitterionic polysaccharides.
    Ruiz-Perez B; Chung DR; Sharpe AH; Yagita H; Kalka-Moll WM; Sayegh MH; Kasper DL; Tzianabos AO
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16753-8. PubMed ID: 16275921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation.
    Stephen TL; Niemeyer M; Tzianabos AO; Kroenke M; Kasper DL; Kalka-Moll WM
    Infect Immun; 2005 Apr; 73(4):2184-9. PubMed ID: 15784561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR.
    Cobb BA; Kasper DL
    Glycobiology; 2008 Sep; 18(9):707-18. PubMed ID: 18525076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions.
    Kalka-Moll WM; Tzianabos AO; Bryant PW; Niemeyer M; Ploegh HL; Kasper DL
    J Immunol; 2002 Dec; 169(11):6149-53. PubMed ID: 12444118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary Role of CD4+ T Cells in Response to Pneumococcal Polysaccharide Vaccines in Humans.
    Jha V; Janoff EN
    Vaccines (Basel); 2019 Feb; 7(1):. PubMed ID: 30754689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses.
    Nishat S; Andreana PR
    Vaccines (Basel); 2016 May; 4(2):. PubMed ID: 27213458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic zwitterionic polysaccharides.
    Zhang Q; Overkleeft HS; van der Marel GA; Codée JD
    Curr Opin Chem Biol; 2017 Oct; 40():95-101. PubMed ID: 28888143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycans as Vaccine Antigens and Adjuvants: Immunological Considerations.
    Zimmermann S; Lepenies B
    Methods Mol Biol; 2015; 1331():11-26. PubMed ID: 26169732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting dendritic cells for priming cellular immune responses.
    Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
    J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines: a review of developments.
    Webster RG; Robinson HL
    BioDrugs; 1997 Oct; 8(4):273-92. PubMed ID: 18020519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrates as T-cell antigens with implications in health and disease.
    Sun L; Middleton DR; Wantuch PL; Ozdilek A; Avci FY
    Glycobiology; 2016 Oct; 26(10):1029-1040. PubMed ID: 27236197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-Induced CD8
    Beijnen EMS; van Haren SD
    Front Immunol; 2020; 11():607977. PubMed ID: 33424857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor β and the frequency of regulatory T cells.
    Du X; Chen X; Zhao B; Lv Y; Zhang H; Liu H; Chen Z; Chen Y; Zeng X
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):228-35. PubMed ID: 22077226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.